ArticleCancers2024

CPX-351 Pharmacokinetics and Safety in Adults with Hematologic Malignancies and Renal Function Impairment: Phase 1 Trial.

Scott R Solomon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.